Christopher J. Ryerson
Christopher J. Ryerson publishes mostly in Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Physiology, on topics such as Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Chronic Obstructive Pulmonary Disease (COPD) Research and Systemic Sclerosis and Related Diseases.
- World rank
- #20,060 of 7,710,434 ranked researchers
- Rank in Canada
- #430 of 183,316
- Works
- 436
- Citations
- 32k
- Citations per work
- 74.2
What does Christopher J. Ryerson research?
Christopher J. Ryerson's work is mostly in Medicine (83%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences36283.0%
- Medicine36283.0%
- Everything else7417.0%
- 1Pulmonary and Respiratory Medicine60% of their works
- 2Pathology and Forensic Medicine8% of their works
- 3Physiology6% of their works
- 4Epidemiology5% of their works
- 5Neurology2% of their works
- 6Surgery2% of their works
Research topics
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Systemic Sclerosis and Related Diseases
- Medical Imaging and Pathology Studies
- Sarcoidosis and Beryllium Toxicity Research
- Inflammatory Myopathies and Dermatomyositis
- Pulmonary Hypertension Research and Treatments
- Occupational and environmental lung diseases
Which keywords describe Christopher J. Ryerson's research?
The keywords of their largest research topics: Fibrosis, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, TGF-ß, Diagnosis, Management, Autoantibodies and Treatment.
- BAP1 mutations
- Pulmonary Hypertension
- Dermatomyositis
- Cardiac
- Pulmonary Alveolar Microlithiasis
- Pulmonary Involvement
- COPD
- Treatment
- Management
- TGF-ß
- Interstitial Lung Disease
- Fibrosis
- Idiopathic Pulmonary Fibrosis
- Diagnosis
- Autoantibodies
- Endothelial Dysfunction
- spirometry
- Systemic Sclerosis
- Pulmonary Sclerosing Hemangioma
- Sarcoidosis
- Inflammatory Myopathies
- Right Heart Assessment
- Malignant Pleural Mesothelioma
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Fibrosis4222 topics
- Interstitial Lung Disease3842 topics
- Idiopathic Pulmonary Fibrosis3361 topic
- TGF-ß3361 topic
- Diagnosis1812 topics
- Management1812 topics
- Autoantibodies1342 topics
- Treatment1342 topics
- Endothelial Dysfunction1312 topics
- COPD1201 topic
- spirometry1201 topic
- Pulmonary Involvement861 topic
- Systemic Sclerosis861 topic
- Pulmonary Alveolar Microlithiasis771 topic
- Pulmonary Sclerosing Hemangioma771 topic
- Cardiac611 topic
- Sarcoidosis611 topic
- Dermatomyositis481 topic
- Inflammatory Myopathies481 topic
- Pulmonary Hypertension451 topic
- Right Heart Assessment451 topic
- BAP1 mutations271 topic
- Malignant Pleural Mesothelioma271 topic
Where does Christopher J. Ryerson work?
Christopher J. Ryerson's main affiliation in the publication record is University of British Columbia, Canada.
How many publications and citations does Christopher J. Ryerson have?
OpenAlex counts 436 works and 32,340 citations for Christopher J. Ryerson, an h-index of 72, ranking #20,060 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Christopher J. Ryerson. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.